WilmerHale represented Thermo Fisher Scientific Inc. in connection with its offer and sale of $600,000,000 aggregate principal amount of its 4.953% Senior Notes due 2026, $750,000,000 aggregate principal amount of its 4.977% Senior Notes due 2030, $1,000,000,000 aggregate principal amount of its 5.086% Senior Notes due 2033 and $600,000,000 aggregate principal amount of its 5.404% Senior Notes due 2043. The offering priced on August 7, 2023 and closed on August 10, 2023. BNP Paribas Securities Corp., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Mizuho Securities USA LLC acted as representatives of the underwriters for the offering.
The WilmerHale team advising Thermo Fisher Scientific Inc. on the offering consisted of Molly Fox, Justin Ochs, Andrew Langworthy, Ryan S. Brewer and Rachael Joseph (Capital Markets), with assistance from Julie Hogan-Rodgers (Tax).